Previous 10 | Next 10 |
home / stock / biov:cc / biov:cc news
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , March 22, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") announces that it intends to complete a non-brokered private placeme...
A look at the top 10 most actives in Canada Pharmala Biotech Holdings Inc. (MDMA) rose 18.2% to $0.195 on volume of 1,738,488 shares Cryptobox Technologies Inc. (BLOX) fell 31.5% to $0.37 on volume of 1,509,853 shares ParcelPal Logistics Inc. (PKG) rose 0.0% to $0.015 on volume of 1,349,8...
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update Canada NewsWire VANCOUVER, BC , March 7, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the man...
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order PR Newswire VANCOUVER, BC , March 6, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") today announced that the Ontario Securities Commissi...
BioVaxys Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications Canada NewsWire VANCOUVER, BC , March 5, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"...
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC. Canada NewsWire VANCOUVER, BC , Feb. 21, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQ...
A look at the top 10 most actives in Canada CI First Asset Energy Giants Covered Call ETF (NXF) rose 0.0% to $5.89 on volume of 2,722,351 shares Harvest Healthcare Leaders Income ETF (HHL) rose 0.0% to $8.25 on volume of 2,431,137 shares Goldn Futures Mineral Corp Com (FUTR) rose 50.0% to...
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc. Canada NewsWire VANCOUVER, BC , Feb. 12, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BioVaxys and Procare Health Agree to Termination of USA Distribution Agreement for Papilocare Canada NewsWire VANCOUVER, BC , Dec. 21, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that as ...
BioVaxys in Non-Binding Discussions for Major Immunotherapeutics Technology Acquisition Canada NewsWire VANCOUVER, BC , Dec. 13, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that it i...
News, Short Squeeze, Breakout and More Instantly...
Biovaxys Technology Corp. Company Name:
BIOV:CC Stock Symbol:
CNQC Market:
Biovaxys Technology Corp. Website:
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor Canada NewsWire VANCOUVER, BC , July 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison , ...
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF TRIAL TO TEST IMMUNOCONTRACEPTION IN ASIAN ELEPHANTS Canada NewsWire VANCOUVER, BC and MADISON, Wis. , July 17, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order PR Newswire VANCOUVER, BC , May 16, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (...